PURPOSE OF REVIEW: Atherosclerosis is characterized by a strong inflammatory component. One factor contributing to inflammation in the arterial intima is the complement system. Here we summarize recent progress in the field of complement research on atherogenesis. RECENT FINDINGS: The complement system is activated in human atherosclerotic lesions and is actively regulated by the local synthesis of complement components and of complement regulatory proteins. Potential triggers of complement activation in the arterial intima include immunocomplexes, C-reactive protein, modified lipoproteins, apoptotic cells, and cholesterol crystals. Complement activation releases anaphylatoxins, and anaphylatoxin receptors have been identified in human atherosclerotic lesions. However, experiments on genetically engineered mice with severe hyperlipidemia have been unable to show a major role for complement in experimental atherogenesis. SUMMARY: In humans there is extensive circumstantial evidence for a role of complement in atherosclerosis, which is somewhat contradictory to recent modest or negative findings in atherosclerosis-prone genetically engineered hyperlipidemic mice.
PURPOSE OF REVIEW: Atherosclerosis is characterized by a strong inflammatory component. One factor contributing to inflammation in the arterial intima is the complement system. Here we summarize recent progress in the field of complement research on atherogenesis. RECENT FINDINGS: The complement system is activated in humanatherosclerotic lesions and is actively regulated by the local synthesis of complement components and of complement regulatory proteins. Potential triggers of complement activation in the arterial intima include immunocomplexes, C-reactive protein, modified lipoproteins, apoptotic cells, and cholesterol crystals. Complement activation releases anaphylatoxins, and anaphylatoxin receptors have been identified in humanatherosclerotic lesions. However, experiments on genetically engineered mice with severe hyperlipidemia have been unable to show a major role for complement in experimental atherogenesis. SUMMARY: In humans there is extensive circumstantial evidence for a role of complement in atherosclerosis, which is somewhat contradictory to recent modest or negative findings in atherosclerosis-prone genetically engineered hyperlipidemic mice.
Authors: Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke Journal: J Clin Invest Date: 2007-03 Impact factor: 14.808
Authors: Boudewijn Klop; Pieter van der Pol; Robin van Bruggen; Yanan Wang; Marijke A de Vries; Selvetta van Santen; Joseph O'Flynn; Gert-Jan M van de Geijn; Tjin L Njo; Hans W Janssen; Peter de Man; J Wouter Jukema; Ton J Rabelink; Patrick C N Rensen; Cees van Kooten; Manuel Castro Cabezas Journal: J Biol Chem Date: 2014-10-27 Impact factor: 5.157
Authors: Denis A Mogilenko; Igor V Kudriavtsev; Andrey S Trulioff; Vladimir S Shavva; Ella B Dizhe; Boris V Missyul; Alexander V Zhakhov; Alexander M Ischenko; Andrej P Perevozchikov; Sergey V Orlov Journal: J Biol Chem Date: 2011-12-22 Impact factor: 5.157
Authors: Kelly A Volcik; Christie M Ballantyne; Michael C Braun; Josef Coresh; Thomas H Mosley; Eric Boerwinkle Journal: Am J Hypertens Date: 2008-02-21 Impact factor: 2.689
Authors: Masashi Suzuki; Lev Becker; David K Pritchard; Sina A Gharib; Ellen M Wijsman; Theo K Bammler; Richard P Beyer; Tomas Vaisar; John F Oram; Jay W Heinecke Journal: Arterioscler Thromb Vasc Biol Date: 2012-10-04 Impact factor: 8.311